National Association of Testing Authorities, Australia
Scope of Accreditation
Altona North Medical Group
Site
Altona North Medical Group
Accreditation No.
20574
Site No.
24668
Date of Accreditation
19 Sep 2019
Contact
Ms Stavroula Gerakoulakos
P: +61 (03) 93933900
Availability
Services not available to external clients
Supervision
M (Medical Practice)
Scope of Accreditation
Altona North Medical Group
ISO 15189 (2012)
- This facility complies with the relevant National Pathology Accreditation Advisory Council (NPAAC) requirements.
Human Pathology
Medicare expiry date
25 Dec 2024
Last Activity Date
01 Jul 2021
| Service | Product | Determinant |
|---|---|---|
| Chemical pathology - Diagnosis and management of diabetes mellitus | Blood | Glycated haemoglobin (HbA1c) |
| Chemical pathology - Investigation and determination of hepatic, cardiac, bone, skeletal muscle and other profiles and metabolic studies | Blood | C-reactive protein (CRP); Cholesterol - HDL; Cholesterol - Total; Triglycerides |
| Urine | Albumin/creatinine ratio (ACR) |
The only data displayed is that deemed relevant and necessary for the clear description of the activities and services covered by the scope of accreditation.
Grey text appearing in a SoA is additional freetext providing further refinement or information on the data in the preceding line entry.
Accreditation No.
20574
Site No.
24668
Print date
20 Apr 2024
END OF SCOPE
